| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c5a098f9efea2799b03c7b0d5d5e252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0c41591753575ea39a07a95e6a58387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7997126de7f7e531e4bb5a8f94f1d3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_251d7403f730f185dccad91b1cd19d1c |
| publicationDate |
2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010003289-A1 |
| titleOfInvention |
Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation Thereof |
| abstract |
A controlled release combination formulation for oral administration comprising a) a controlled release portion containing metformin or a pharmaceutically acceptable salt thereof as an active ingredient, and a combination of a polyethylene oxide and a natural gum as a carrier for controlled release; and b) a rapid-release portion containing a sulfonylurea-based medicine for treating diabetes as an active ingredient coated on the controlled release portion is useful for the treatment of diabetes, for it is capable of maintaining an effective concentration of the medicines in blood at a constant level. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011014299-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8900638-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011093612-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10866140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010136127-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9694007-B2 |
| priorityDate |
2004-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |